Abstract

Intermediate-conductance Ca2+-activated K+ (IK) channels are calcium/calmodulin-regulated voltage-independent K+ channels. Activation of IK currents is important in vessel and respiratory tissues, rendering the channels potential drug targets. A variety of small organic molecules have been synthesized and found to be potent activators of IK channels. However, the poor selectivity of these molecules limits their therapeutic value. Venom-derived peptides usually block their targets with high specificity. Therefore, we searched for novel peptide activators of IK channels by testing a series of toxins from spiders. Using electrophysiological experiments, we identified hainantoxin-I (HNTX-I) as an IK-channel activator. HNTX-I has little effect on voltage-gated Na+ and Ca2+ channels from rat dorsal root ganglion neurons and on the heterologous expression of voltage-gated rapidly activating delayed rectifier K+ channels (human ether-à-go-go-related gene; human ERG) in HEK293T cells. Only 35.2% ± 0.4% of the currents were activated in SK channels, and there was no effect on BK channels. We demonstrated that HNTX-I was not a phrenic nerve conduction blocker or acutely toxic. This is believed to be the first report of a peptide activator effect on IK channels. Our study suggests that the activity and selectivity of HNTX-I on IK channels make HNTX-I a promising template for designing new drugs for cardiovascular diseases.

Highlights

  • The intermediate-conductance Ca2+-activated K+ (IK) channels belong to the gene family of calcium/calmodulin-regulated and voltage-independent K+ channels (SK1/SK2/SK3 and IK) [1] and contribute to cellular functions by producing membrane hyperpolarization, regulating intracellular

  • Many studies in animals and even clinical studies have shown that decreased IK-channel activity is associated with endothelial dysfunction in cardiovascular diseases

  • Endothelium-dependent vasodilatation is mediated by nitric oxide (NO), prostacyclin and an endothelium-derived hyperpolarizing factor (EDHF), and it involves IK channels [5]

Read more

Summary

Introduction

The intermediate-conductance Ca2+-activated K+ (IK) channels belong to the gene family of calcium/calmodulin-regulated and voltage-independent K+ channels (SK1/SK2/SK3 and IK) [1] and contribute to cellular functions by producing membrane hyperpolarization, regulating intracellular. IK channel modulators mainly comprise small organic compounds and venom-derived peptides [6] These different classes of chemicals modulate the channel by binding to either the external or the internal face of the ion-conducting pore. In keeping with the uncertain or weak selectivity of some of the activators, caution is indicated in interpreting results when using higher dosages in vitro and in vivo [8] For this reason, we screened for peptide-positive gating modulators from venom-derived peptides as alternatives to the existing small organic activators. Our previous works demonstrated that HNTX-I shows no effect on the neuronal TTX-S VGSCs in adult rat dorsal root ganglion neurons nor does it target VGSCs in cardiac or skeletal muscles of mammals It selectively blocks rNav1.2/β1 and para/tipE channels expressed in Xenopus laevis oocytes. A phrenic nerve conduction study and a toxicity test of mouse increase the pharmaceutical value of HNTX-I

Defining the HNTX-I for hIK1 Activate
HNTX-I Is a Highly Selective Activator of hIK1 Current
HNTX-I Has No Obvious Block on Phrenic Nerve Conduction in Mice
HNTX-I Is Nontoxic in an in vivo Toxicity Test
Toxins
Electrophysiology
Blocked Studies of Phrenic Nerve Conduction
Acute in vivo Toxicity Determinations
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call